相似文献/References:
[1]张海君,闫卫东,邝先奎.吉西他滨联合顺铂治疗晚期非小细胞肺癌30 例[J].新乡医学院学报,2003,20(06):428.
[2]李勇莉,高福莲.mdr1介导的多药耐药及其逆转的研究进展 [J].新乡医学院学报,2006,23(03):000.
[3]刘鹏辉,廖国清,王红梅.非小细胞肺癌化疗前后肿瘤标记物水平变化及意义 [J].新乡医学院学报,2007,24(01):038.
[4]李艳,黄新恩,陈颖波,等.XPD751和XRCC1399联合基因型与非小细胞肺癌化疗毒性的关系[J].新乡医学院学报,2010,27(03):230.
[5]靳彩玲,寇小格,苗战会.人参皂苷Rg3 联合化学治疗对老年非小细胞肺癌术后辅助治疗的临床观察[J].新乡医学院学报,2011,28(02):229.
[6]王志慧,梁文辉,原志庆,等.缺氧诱导因子-2α对乳腺癌细胞多药耐药的影响[J].新乡医学院学报,2018,35(11):961.[doi:10.7683/xxyxyxb.2018.11.004]
WANG Zhi-hui,LIANG Wen-hui,YUAN Zhi-qing,et al.Effect of hypoxia inducible factor-2α induce multidrug resistance in breast cancer[J].Journal of Xinxiang Medical University,2018,35(05):961.[doi:10.7683/xxyxyxb.2018.11.004]
[7]李 琴,闫瑞芳,靳平宁.结肠癌长春新碱耐药细胞中微小核糖核酸表达分析[J].新乡医学院学报,2017,34(3):170.[doi:10.7683/xxyxyxb.2017.03.003]
LI Qin,YAN Rui-fang,JIN Ping-ning.Analysis of microRNA expression in vincristine-resistant colon cancer cell line[J].Journal of Xinxiang Medical University,2017,34(05):170.[doi:10.7683/xxyxyxb.2017.03.003]
[8]何社红,薛聪玲.谷胱甘肽转移酶-π与卵巢癌多药耐药的关系[J].新乡医学院学报,2017,34(4):320.[doi:10.7683/xxyxyxb.2017.04.020]
HE She-hong,XUE Cong-ling.Relationship between glutathione S-transferase-π and multidrug resistance of ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(05):320.[doi:10.7683/xxyxyxb.2017.04.020]
[9]何社红,薛聪玲.蛋白激酶C活性与卵巢癌多药耐药性的相关性[J].新乡医学院学报,2017,34(7):660.[doi:10.7683/xxyxyxb.2017.07.029]
HE She-hong,XUE Cong-ling.Correlation between protein kinase C activity and multidrug resistance in ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(05):660.[doi:10.7683/xxyxyxb.2017.07.029]